Clinical trial
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple…
NCT00470093 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated
Key facts
| NCT number | NCT00470093 |
|---|---|
| Title | Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma |
| Official title | A Pilot Study of Differentiation Therapy in Multiple Myeloma Using Interleukin-6 and Interferon-a |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological |
| Interventions | recombinant interferon-α, recombinant interleukin-6 |
| Enrollment | 3 |
| Start date | Oct 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | May 7, 2007 |
| Last update posted | Nov 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: